Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Circadin for Non-24 Hour Sleep-Wake Disorder in Blind Subjects
NCT00972075Phase 2Completed
- Sponsor
- Neurim Pharmaceuticals
- Start
- Feb 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in Non-24-hour sleep-wake disorder (N24SWD), sponsored by Neurim Pharmaceuticals. Started Feb 2006; status: completed.
02
Drugs
melatonin
03
Conditions
Non-24-hour sleep-wake disorder (N24SWD)
Beyond the preview
Go deeper on NCT00972075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00972075.